Patient 1 did well at 6 and 12 weeks.  Patient 2 did ok at 6 weeks and the cancer was growing at 12 weeks. 

 

It is possible that the move higher is because results of the 3 month scan the happened over the last few weeks is leaking.  I am sure that any investors that have the ability to get inside info would wait for the 12 week scan prior to buying.  

 

A 6 week scan with a decrease of 25-50% is fine.  But based on the first 2 patients investors would want the 12 week scan data.  If patient 3 saw the tumor continue to decrease in mass at 12 weeks it would be a very positive results. 

 

Patient 1 saw 46% decrease at 6 weeks and 52.5% at 12 weeks. 

Patient 2 saw only a 15% decrease at 6 weeks and the tumors was growing at 12 weeks.

 

Patient 3 likely had positive results at 6 weeks.  I would like to know if it was 15% or 45%. But the most important info will be 12 weeks.  Did the t-cells continue to eat the cancer cells or did the tumor begin to grow.